AU2001284324A1 - Controlled release formulation of erythromycin or a derivative thereof - Google Patents

Controlled release formulation of erythromycin or a derivative thereof

Info

Publication number
AU2001284324A1
AU2001284324A1 AU2001284324A AU8432401A AU2001284324A1 AU 2001284324 A1 AU2001284324 A1 AU 2001284324A1 AU 2001284324 A AU2001284324 A AU 2001284324A AU 8432401 A AU8432401 A AU 8432401A AU 2001284324 A1 AU2001284324 A1 AU 2001284324A1
Authority
AU
Australia
Prior art keywords
erythromycin
derivative
controlled release
release formulation
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284324A
Other languages
English (en)
Inventor
Manoj Kumar
Rajeev S. Raghuvanshi
Ashok Rampal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2001284324A1 publication Critical patent/AU2001284324A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001284324A 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof Abandoned AU2001284324A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN778/DEL/2000 2000-08-29
IN778DE2000 IN192748B (enrdf_load_stackoverflow) 2000-08-29 2000-08-29
PCT/IB2001/001564 WO2002017885A2 (en) 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof

Publications (1)

Publication Number Publication Date
AU2001284324A1 true AU2001284324A1 (en) 2002-03-13

Family

ID=11097084

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284324A Abandoned AU2001284324A1 (en) 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof

Country Status (5)

Country Link
US (1) US20020081332A1 (enrdf_load_stackoverflow)
EP (1) EP1315478A2 (enrdf_load_stackoverflow)
AU (1) AU2001284324A1 (enrdf_load_stackoverflow)
IN (1) IN192748B (enrdf_load_stackoverflow)
WO (1) WO2002017885A2 (enrdf_load_stackoverflow)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
HRP20020709A2 (en) * 2000-02-29 2004-12-31 Teva Pharma Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
BR0109544A (pt) * 2000-03-28 2003-06-10 Biochemie Gmbh Partìculas granuladas com sabor ocultado
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US6673369B2 (en) 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
WO2003045308A2 (en) * 2001-11-21 2003-06-05 E-Z-Em, Inc. Formulations for use in medical or diagnostic procedures
AU2003214504A1 (en) * 2002-04-03 2003-10-13 Ranbaxy Laboratories Limited Taste masked compositions of erythromycin a and derivatives thereof
WO2003082241A2 (en) * 2002-04-03 2003-10-09 Ranbaxy Laboratories Limited Clarithromycin formulations having improved bioavailability
US7063862B2 (en) * 2003-06-03 2006-06-20 Biokey, Inc. Pharmaceutical composition and method for treating
WO2005004919A2 (en) * 2003-07-02 2005-01-20 Eurand, Inc. Extended release systems for macrolide antibiotics
AU2004258944B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1646367A4 (en) * 2003-07-21 2011-06-15 Nesher Solutions Ltd ORAL DOSAGE FORMS WITH CONTROLLED RELEASE ON GELLAN RUBBER BASE A NEW PLATFORM TECHNOLOGY FOR MAGNETIC RETENTION
EP1648415A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1653925A1 (en) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
JP5686494B2 (ja) 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
US8460710B2 (en) 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
US8168228B2 (en) 2003-10-17 2012-05-01 Sandoz Ag Antibiotic clarithromycin micropellet compositions
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US20050260263A1 (en) * 2004-05-18 2005-11-24 Panion & Bf Biotech Inc. Sustained release formulation for sparingly soluble main drugs
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2011125075A2 (en) * 2010-04-08 2011-10-13 Fdc Limited A novel gastroretentive delivery of macrolide
EP2671571A1 (en) * 2012-06-05 2013-12-11 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-release formulations of clarithromycin
CN118903019B (zh) * 2024-10-11 2025-02-07 山东亚康药业股份有限公司 一种缓释硫氰酸红霉素可溶性粉及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076804A (en) * 1975-07-18 1978-02-28 Abbott Laboratories Erythromycin therapy
GB1577196A (en) * 1977-06-03 1980-10-22 Ile De France Compositions containing erythromycin and metoclopramide
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
ES2204098T3 (es) * 1998-09-14 2004-04-16 Ranbaxy Laboratories, Ltd. Sistema de suministro controlado de medicamentos por via oral con control en el tiempo y en el espacio.
SI20150A (sl) * 1999-02-19 2000-08-31 Lek, Tovarna Farmacevtskih In Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina

Also Published As

Publication number Publication date
US20020081332A1 (en) 2002-06-27
WO2002017885A3 (en) 2002-09-06
WO2002017885A2 (en) 2002-03-07
EP1315478A2 (en) 2003-06-04
IN192748B (enrdf_load_stackoverflow) 2004-05-15

Similar Documents

Publication Publication Date Title
AU2001284324A1 (en) Controlled release formulation of erythromycin or a derivative thereof
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU2001286677A1 (en) Controlled release of substances
AU2002215218A1 (en) Isoxazole derivatives
AU2002248377A1 (en) A controlled release pharmaceutical composition
IL149033A0 (en) Extended release formulations of erythromycin derivatives
AU2001290825A1 (en) Controlled release formulations and methods for their production and use
AU2001264256A1 (en) Plaster
AU2001271027A1 (en) Ester derivatives
IL239999A0 (en) Controlled-release hydrocodone formulations
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU2001252679A1 (en) Plaster
AU2001278694A1 (en) Avermectin derivatives
AU2001287977A1 (en) Controlled release formulations for oral administration
AU2001252247A1 (en) Isothiazole derivatives
AU2001232948A1 (en) Controlled release of drugs
AU4213299A (en) Controlled release of substances
AU5256301A (en) Froindazole derivative
AU2001246861A1 (en) Sustained release preparations
AU5246901A (en) A coating composition for facilitating controlled release
AU6589200A (en) Extended release formulation of etodolac
AU2001295855A1 (en) Chocolate spread
AU7887400A (en) A slow release pharmaceutical composition
AU2002230386A1 (en) Sixteen-membered macrolide compounds
HK1056835A (en) Controlled release formulation of erythromycin or a derivative thereof